AIFF SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 31, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Firefly Neuroscience Appoints Jessica Paz as Chief Accounting Officer and Terminates CFO Paul Krzywicki

Sep 14, 2026

8-K

Firefly Neuroscience, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Aug 7, 2026

8-K

Firefly Neuroscience, Inc. Terminates Securities Purchase Agreement

Jun 26, 2026

8-K

Firefly Neuroscience, Inc. Announces Leadership Transition for Gil Issachar

Jun 22, 2026

8-K

Firefly Neuroscience, Inc. Enters into $1 Million Securities Purchase Agreement

May 12, 2026

8-K

Firefly Neuroscience, Inc. Consummates $8 Million Additional Closing Under Securities Purchase Agreement

Apr 22, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 20,499,999

Jul 2, 2026

424B5

February 2026 ATM | Offering amount: $7,434,266 | Bank: Konik Capital Partners, LLC

Feb 3, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 6,009,281 | Warrants amount: 600,000 | Warrants exercise price: $3.50

Aug 29, 2025

425

Common Stock, par value $0.001 per share

Mar 8, 2024

425

Common Stock, par value $0.001 per share

Feb 22, 2024

424B3

UPDATED

Feb 8, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-3/A

SHARE RESALE REGISTRATION

Jun 23, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 20, 2026

S-3

SHARE RESALE REGISTRATION

May 20, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Apr 16, 2026

S-3

December 2025 SHELF

Dec 3, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 17, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 9, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Jun 29, 2026

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

Oct 23, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Oct 3, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Sep 22, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jan 21, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Vnook Stella (Reporting)

Sep 29, 2026

POSNER BRIAN M (Reporting)

Sep 29, 2026

Menawat Arun Swarup (Reporting)

Sep 29, 2026

Paz Jessica Lucia (Reporting)

Sep 14, 2026

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Jun 23, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

May 20, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 1, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 8, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 23, 2025

CORRESP

Form CORRESP - Correspondence

Jul 18, 2025

LETTER

Form UPLOAD - SEC-generated letter

Jul 10, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 14, 2025

Firefly Neuroscience, Inc. AIFF · SEC Filings